Calamos Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$129M Buy
309,379
+58,491
+23% +$21.7M 0.43% 40
2026
Q1
$67.9M Buy
250,888
+11,085
+5% +$3.3M 0.24% 92
2025
Q4
$79.2M Sell
239,803
-7,080
-3% -$2.4M 0.3% 70
2025
Q3
$85.2M Sell
246,883
-40,212
-14% -$12.2M 0.31% 64
2025
Q2
$89.6M Sell
287,095
-17,829
-6% -$6.81M 0.35% 54
2025
Q1
$160M Sell
304,924
-30,450
-9% -$15.6M 0.7% 18
2024
Q4
$170M Buy
335,374
+26,481
+9% +$15M 0.71% 18
2024
Q3
$181M Buy
308,893
+5,379
+2% +$3.04M 0.78% 16
2024
Q2
$155M Sell
303,514
-11,974
-4% -$5.87M 0.69% 17
2024
Q1
$156M Sell
315,488
-66,113
-17% -$33.6M 0.74% 15
2023
Q4
$201M Sell
381,601
-9,048
-2% -$4.83M 0.97% 11
2023
Q3
$197M Buy
390,649
+7,047
+2% +$3.47M 1.02% 12
2023
Q2
$184M Sell
383,602
-3,774
-1% -$1.85M 0.91% 11
2023
Q1
$183M Sell
387,376
-41,227
-10% -$19.9M 0.89% 10
2022
Q4
$227M Sell
428,603
-55,072
-11% -$29.2M 1.07% 7
2022
Q3
$244M Sell
483,675
-6,184
-1% -$3.25M 1.12% 6
2022
Q2
$252M Sell
489,859
-9,605
-2% -$4.82M 1.09% 7
2022
Q1
$255M Buy
499,464
+46,786
+10% +$22.6M 0.96% 9
2021
Q4
$227M Buy
452,678
+7,938
+2% +$3.59M 0.85% 12
2021
Q3
$174M Buy
444,740
+10,847
+2% +$4.49M 0.76% 14
2021
Q2
$174M Buy
433,893
+78,423
+22% +$31.3M 0.79% 13
2021
Q1
$132M Buy
355,470
+1,708
+0.5% +$592K 0.72% 18
2020
Q4
$124M Buy
353,762
+15,517
+5% +$5.2M 0.72% 18
2020
Q3
$105M Sell
338,245
-19,728
-6% -$6.06M 0.68% 18
2020
Q2
$106M Sell
357,973
-99,064
-22% -$28.4M 0.75% 16
2020
Q1
$114M Sell
457,037
-66,054
-13% -$18.2M 0.89% 11
2019
Q4
$154M Sell
523,091
-23,147
-4% -$6.06M 0.76% 16
2019
Q3
$119M Buy
546,238
+18,978
+4% +$4.58M 0.65% 25
2019
Q2
$129M Buy
527,260
+10,242
+2% +$2.46M 0.71% 20
2019
Q1
$128M Buy
517,018
+3,393
+0.7% +$865K 0.8% 13
2018
Q4
$128M Sell
513,625
-17,383
-3% -$4.59M 0.84% 14
2018
Q3
$141M Sell
531,008
-41,029
-7% -$10.7M 0.78% 15
2018
Q2
$140M Buy
572,037
+55,824
+11% +$13.4M 0.86% 13
2018
Q1
$110M Buy
516,213
+163,116
+46% +$37.3M 0.72% 22
2017
Q4
$77.8M Sell
353,097
-112,839
-24% -$23.9M 0.4% 39
2017
Q3
$91.3M Sell
465,936
-66,340
-12% -$12.8M 0.71% 23
2017
Q2
$98.7M Buy
532,276
+1,482
+0.3% +$260K 0.73% 23
2017
Q1
$87.1M Buy
530,794
+92,964
+21% +$15.2M 0.69% 26
2016
Q4
$70.1M Buy
437,830
+169,545
+63% +$25.3M 0.56% 41
2016
Q3
$37.6M Sell
268,285
-139
-0.1% -$19.5K 0.27% 117
2016
Q2
$37.9M Buy
268,424
+173,841
+184% +$23.2M 0.27% 117
2016
Q1
$12.2M Buy
94,583
+5,806
+7% +$687K 0.08% 244
2015
Q4
$10.4M Sell
88,777
-1,840
-2% -$215K 0.07% 264
2015
Q3
$10.5M Sell
90,617
-5,171
-5% -$619K 0.07% 257
2015
Q2
$11.7M Sell
95,788
-4,144
-4% -$490K 0.07% 247
2015
Q1
$11.8M Buy
99,932
+7,854
+9% +$872K 0.07% 250
2014
Q4
$9.31M Buy
92,078
+478
+0.5% +$45.3K 0.06% 274
2014
Q3
$7.9M Hold
91,600
0.05% 286
2014
Q2
$7.49M Buy
91,600
+6,600
+8% +$519K 0.05% 288
2014
Q1
$6.97M Hold
85,000
0.04% 279
2013
Q4
$6.4M Hold
85,000
0.04% 286
2013
Q3
$6.09M Hold
85,000
0.04% 281
2013
Q2
$5.57M Buy
+85,000
New +$5.29M 0.04% 279

Other funds holding UNH

Calamos Advisors's UNH Position: Q2 2026 in Review

Calamos Advisors increased its UnitedHealth (UNH) stake by 23% in Q2 2026, buying an estimated $21.7M and bringing the position to 309,379 shares worth $129M. The position accounts for 0.43% of the portfolio, ranked #40.

Calamos Advisors first reported a position in UNH in Q2 2013 and has held it in 53 quarters since. The position peaked at $255M in Q1 2022. 1,635 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Calamos Advisors held 309,379 shares of UnitedHealth worth $129M as of Q2 2026.
  • Calamos Advisors bought 58,491 UnitedHealth shares in Q2 2026, an estimated $21.7M.
  • UnitedHealth made up 0.43% of Calamos Advisors's portfolio in Q2 2026, its #40 holding.
  • Calamos Advisors first reported a position in UnitedHealth in Q2 2013 and has held it in 53 quarters since.
  • Calamos Advisors's UnitedHealth position peaked at $255M in Q1 2022.
  • 1,635 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.